Market Research Logo

Vaccines 2014: World Market Analysis with Forecasts to 2020, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)

Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

The global market for human vaccines experienced strong growth through 2013 with the introduction of new vaccines. These new products and other trends are well-covered in Vaccines: The World Market. The Kalorama information report examines the global market for vaccines, covering specifically commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable.

Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission. The high growth rates and successful launch of several recent products have kept interest in the global vaccine market high. This report investigates the changes vaccine manufacturers have undergone in the past year, providing world market analysis, identifying the key players, and outlining critical trends in this fast-changing industry.

Included in this report are current market size and forecasts to 2020 for the following vaccines:

Pediatric Vaccines:

  • Pneumococcal
  • Combinations
  • Varicella
  • MMR
  • Poliovirus
  • Hepatitis
  • HIB
  • Other Pediatric
Adult Vaccines:
  • Influenza
  • Cervical Cancer
  • Hepatitis
  • Pneumococcal
  • Travel; DT; Misc.
The global market for vaccines experienced strong growth in many categories through 2013, declines in others, and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Kalorama provides a global perspective in this report, including estimates of vaccine sales (pediatric and adult segments) in the following regions:
  • U.S.
  • Rest of North Amer.
  • South America
  • Europe
  • Japan
  • India
  • China
  • Rest of World
Despite ongoing improvements in pediatric vaccination, it is estimated that at least two million children die each year from diseases that could have been prevented by already existing vaccines. This problem is most significant in low income countries, with the health disparity between rich and poor countries resulting in average life spans of about 77 and 52 years, respectively. In addition to this high death toll, millions more suffer disability and illness because they have not been immunized.

Adult immunization is an important, but frequently overlooked, part of patient care. Though vaccination programs typically focus on children, adults in industrialized countries are more likely to die as a result of vaccine-preventable diseases than are children. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Pharmacoeconomic studies have demonstrated the value of influenza and pneumococcal vaccines; however, immunization rates for these diseases continue to be low in the elderly populations.

Key issues in the global vaccine market today include product safety, refusal to immunize, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems. The following issues are discussed in this report.
  • Vaccine Safety
  • Refusal to Immunize
  • Obesity
  • Post-Licensure Surveillance
  • The Future of Vaccine Safety
  • Vaccine Shortages
  • Preventing Pandemics
  • Project Bioshield Act
  • National Bio and Agro-Defense Facility
  • DNA Vaccination
  • Mucosal Delivery
  • Intranasal Delivery
  • Vaccine Patches
  • Vaccine Chips and Microneedles
  • Innovations in Vaccine Production
  • Nanoparticle Systems
  • Cloning
This report includes profiles of the key players in vaccines, including:
  • AlphaVax, Inc.
  • Bavarian Nordic A/S
  • Baxter Healthcare
  • Bharat Biotech
  • Crucell /Johnson & Johnson
  • Emergent biosolutions
  • GlaxoSmithKline
  • Medimmune
  • Merck & Co. Inc
  • Novartis
  • Sanofi Pasteur
  • Pfizer


  • Executive Summary
    • THE GLOBALVACCINES INDUSTRY
      • Scope and Methodology
      • Overview
      • Pediatric Preventative Vaccines
      • Adult Preventative Vaccines
    • THEMARKET
    • ISSUES AND TRENDS
  • Introduction to Vaccines
    • Table Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2012
    • ABRIEF HISTORY: THE DEVELOPMENT OF VACCINES
    • THE IMMUNE RESPONSE
    • MECHANISM OF ACTION
    • TYPES OF VACCINES
      • Attenuated (Weakened) Live Viruses
      • Killed (Inactivated) Viruses
        • Table Vaccine-Preventable Diseases, March 2014
      • Toxoid Vaccines
      • Genetically Engineered/Modified Vaccines
    • VACCINE APPROVAL PROCESS
      • Table VAERS Table of Reportable Events Following Vaccination
  • Pediatric Preventive Vaccines
    • INTRODUCTION
      • Table Total Number of Children Who Died from Diseases Preventable by Vaccines Recommended by the WHO 2012
    • CHILDHOOD IMMUNIZATION IN THE UNITED STATES
      • Table Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 1990 - 2012
      • Childhood Immunization Rates
      • Challenges to the Vaccine Delivery System
      • The Effect of U.S. Healthcare Reform
        • Table Marketplace Enrollment as a Share of the Eligible Population, December 2013
      • Recommended Childhood Immunization Schedule
        • Table U.S. Recommended Immunization Schedule for Children Ages 0 Through 18 Years, 2013
      • State Immunization Recommendations
      • United Nations Initiatives
    • PEDIATRIC VACCINE PRODUCTS
      • BCG
      • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
      • Haemophilus Influenzae Type B
      • Hepatitis A
      • Measles, Mumps and Rubella
      • Meningococcal Disease
      • Pneumococcal Conjugate
      • Rotavirus
      • Varicella
    • PEDIATRIC VACCINES IN DEVELOPMENT
      • Table Selected Pediatric Vaccines in Development, March 2014
    • COST OF VACCINES IN THE UNITED STATES
    • THEWORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINES
      • Total Market Size and Forecast
        • Table World Market for Pediatric Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others) 2011-2020
        • Table World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2011-2020
      • Hepatitis Vaccine Market
        • Table World Pediatric Hepatitis Vaccine Market 2011-2020
      • Haemophilus Influenzae Type B Vaccine Market
        • Table World Hib Vaccine Market, 2011-2020
      • Measles, Mumps and Rubella Vaccines
        • Table World MMR Vaccines Market 2011-2020
      • Combination Vaccines Market
        • Table World Combination Vaccines Market 2011-2020
      • Pneumococcal Vaccine
        • Table World Pediatric Pneumococcal Vaccine Market 2011-2020
      • Poliovirus Vaccine
        • Table World Poliovirus Vaccine Market 2011-2020
      • Varicella Vaccines
        • Table World Varicella Vaccine Market 2011-2020
      • Other Vaccines Market
        • Table World Pediatric Other Vaccines Market 2011-2020
  • Adult Preventive Vaccines
    • INTRODUCTION
    • ADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURES
    • GLOBAL INFLUENZA SURVEILLANCE PROGRAM
      • U.S. Surveillance
    • RECOMMENDATIONS FOR ADULT IMMUNIZATIONS
      • Table Universal Adult Immunization Schedule 2013
      • Table Summary of Recommendations for Adult Immunization
      • WHO International Health Regulations
    • ADULT VACCINE PRODUCTS
      • Cervical Cancer
        • Table Initiatives to Require HPV Vaccination by U.S. State, 2014
      • Cholera
      • Diphtheria-Tetanus
      • Hepatitis
      • Influenza
        • Table WHO Pandemic Classification Schedule
      • Japanese Encephalitis
      • Pneumococcal Disease
      • Rabies
      • Shingles
      • Typhoid Fever
      • Yellow Fever
    • ADULT VACCINES IN DEVELOPMENT
      • Table Selected Adult Preventive Vaccines in Development, 2014
    • THEWORLD MARKET FOR ADULT PREVENTIVE VACCINES
      • Total Market Size and Forecast
        • Table World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2011-2020
        • Table World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2011-2020
      • Cervical Cancer Market
        • Table World Cervical CancerVaccine Market 2011-2020
      • Hepatitis Market
        • Table World Hepatitis Vaccine Market 2011-2020
      • Influenza Vaccine Market
        • Table World Influenza Vaccine Market 2011-2020
        • Table 2013 Estimated Population by Region and Selected Age Group (in millions)
        • Table World Pneumococcal Vaccine Market 2011-2020
      • Travel, DT, and Miscellaneous Vaccine Market
        • Table World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2011-2020
  • Vaccines Market Summary
    • TRENDS DRIVING THE VACCINES MARKET
    • MARKET SIZE AND FORECAST
      • Table The World Vaccines Market by Vaccine Type 2011-2020
      • United States
      • North America
      • South America
      • Europe
      • Japan
      • India
      • China
      • Rest of World
      • Vaccine Market Competitors
        • Table The World Vaccines Market by Region 2011-2020
        • Table Major Manufacturers' Shares of the World Vaccine Market, 2013
      • Pediatric Vaccines
        • Table Major Manufacturer's Shares of the World Pediatric Vaccine Market 2013
      • Adult Vaccines
        • Table Major Manufacturer's Shares of the World Adult Vaccine Market 2013
  • Issues and Trends
    • VACCINE SAFETY
      • Refusal to Immunize
      • Obesity
      • Post-Licensure Surveillance
      • The Vaccine Injury Compensation Program
      • World Health Organization
      • Other Initiatives
      • The Future of Vaccine Safety
    • VACCINE SHORTAGES
      • Preventing Shortages in the Developed Countries
      • Preventing Shortages in Developing Nations
    • PREVENTING PANDEMICS
      • U.S. National Vaccine Plan
    • VACCINES AND BIOTERRORISM
      • Overview
      • Project Bioshield Act
        • Table Selected Companies/Laboratories Developing Biodefense Vaccines
      • National Bio and Agro-Defense Facility
      • Vaccine Treatment and Evaluation Units
      • Anthrax
      • Smallpox
    • DNAVACCINATION
    • INNOVATIONS IN VACCINE DELIVERY SYSTEMS
      • Mucosal Delivery
      • Intranasal Delivery
      • Vaccine Patches
      • Vaccine Chips and Microneedles
    • INNOVATIONS IN VACCINE PRODUCTION
      • Plants
      • Insects
      • Nanoparticle Systems
      • Cloning
  • Company Profiles
    • ALPHAVAX, INC.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAVARIAN NORDIC A/S
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BAXTER HEALTHCARE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • BHARAT BIOTECH
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • CRUCELL /JOHNSON &JOHNSON
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • EMERGENT BIOSOLUTIONS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial
    • GLAXOSMITHKLINE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MEDIMMUNE
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • MERCK&CO. INC
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • NOVARTIS
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Pfizer
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • SANOFI PASTEUR
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report